Ferrer seeks partner for novel approval-ready antibiotic cream
This article was originally published in Scrip
Executive Summary
Privately held Spanish pharmaceutical company Ferrer has issued an advert for perspective worldwide licensing partners for its impetigo treatment Ozenoxacin on the back of successful Phase III results.